Maastricht University Medical Center
Maastricht, Netherlands
NCT Number: NCT02091427
Acute myocardial infarction (AMI) is defined by an increase and/or decrease in the concentration of cardiac troponin, with at least one value above the 99th percentile value of the reference population together with evidence of ischemia. An objective tool to determine the magnitude of the cardiac troponin change is the use of reference change values (RCV). The basis for this tool is that, for a change to be significant, the difference in serial results must be greater than the inherent variation in two test results. The inherent variation of a laboratory test result is composed of analytical and within-subject biological variation. An important requirement to use RCVs is that the concentrations of cardiac troponins fluctuate randomly around a homeostatic set point in cardio-healthy individuals. Verification of this important condition has never been performed, and violation of this condition would preclude the use of RCV's in clinical practice.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Maastricht, Netherlands
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: measured every hour, total time 25h (08:30 day 1, till 09:30 day 2)
Maastricht University Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06101628
Gel Nail, Healthy Individuals
Mersin, Turkey, Turkey (Türkiye)
View Trial DetailsNCT07054853
Healthy Individuals
Giza, Egypt
View Trial DetailsNCT07495371
Healthy Individuals, Hip Joint Disorders
Roma, RM, Italy
View Trial DetailsNCT06580171
Healthy Individuals
Istanbul, Turkey (Türkiye)
View Trial Details